Unique ID issued by UMIN | UMIN000057599 |
---|---|
Receipt number | R000065812 |
Scientific Title | Test of suppression of postprandial blood glucose elevation by food ingestion |
Date of disclosure of the study information | 2025/04/15 |
Last modified on | 2025/04/12 17:16:49 |
Test of suppression of postprandial blood glucose elevation by food ingestion
Test of suppression of postprandial blood glucose elevation by food ingestion
Test of suppression of postprandial blood glucose elevation by food ingestion
Test of suppression of postprandial blood glucose elevation by food ingestion
Japan |
Healthy Adults
Adult |
Others
NO
To examine the inhibitory effect of test foods on postprandial blood glucose elevation
Efficacy
Changes in postprandial blood glucose levels
Changes in postprandial insulin
Interventional
Cross-over
Randomized
Individual
Double blind -all involved are blinded
Placebo
YES
YES
No need to know
2
Treatment
Food |
Single intake of bitter melon and foods containing corosolic acid
Single intake of placebo foods containing corosolic acid
20 | years-old | <= |
64 | years-old | >= |
Male and Female
(1) Male and female subjects aged 20 to 64 years
(2) Normal to slightly elevated fasting blood glucose level (125 mg/dL or less) at baseline
(3) Subjects who give written voluntary consent to participate in the study
(1) Those who have been diagnosed with diabetes and are currently undergoing treatment
(2) Those who are currently taking medication for diabetes or high blood pressure
(3) Those who are currently taking the test food or health food
(4) Those who regularly take supplements related to cholesterol, blood pressure, blood lipids, or blood sugar levels
(5) Those with serious diseases or mental disorders of the following systems: sugar metabolism, lipid metabolism, liver function, kidney function, heart, circulatory system, respiratory system, endocrine system, immune system, or nervous system. Those with a history of such diseases or disorders
(6) Those who have been found to have abnormal clinical test values and are judged to have problems participating in the study
(7) Those with diseases that are currently being treated or who have a history of serious diseases that required medication treatment
(8) Those who may develop allergies in relation to the study
(9) Those who are judged to be unsuitable as subjects based on the results of the lifestyle questionnaire
(10) Those who are participating in other clinical research at the start of this study
(11) Those who are pregnant or plan to become pregnant or breastfeed during the study period
(12) Those who are judged to be unsuitable for participation in the study by the principal investigator (or the person in charge of conducting the study)
20
1st name | Ryuji |
Middle name | |
Last name | Takeda |
Kansai University of Welfare Sciences
Department of Nutritional Sciences for Welll-being, Faculty of Health Science for Welfare
582-0026
Asahigaoka 3-11-1, Kashiwara, Osaka
072-978-0088
rtakeda@tamateyama.ac.jp
1st name | Shigefumi |
Middle name | |
Last name | Nibun |
EAS inc.
Clinical Trial Session
236-0028
Susaki-Cho1-10-2F, Kanazawa-ku, Yokohama city, Kanagawa
070-5415-3051
info@eas-ct.jp
Lifix Corporation
Lifix Corporation
Profit organization
KOBUNA ORTHOPEDIC SURGERY
311-2, Gokan-machi, Maebashi, Gunma
027-261-7600
sagawa@mc-connect.co.jp
NO
2025 | Year | 04 | Month | 15 | Day |
Unpublished
Preinitiation
2025 | Year | 02 | Month | 10 | Day |
2025 | Year | 02 | Month | 20 | Day |
2025 | Year | 04 | Month | 14 | Day |
2025 | Year | 04 | Month | 30 | Day |
2025 | Year | 04 | Month | 12 | Day |
2025 | Year | 04 | Month | 12 | Day |
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000065812